Rachel Ellingson - Feb 21, 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
SVP & Chief Strategy Officer
Signature
Matthew R. St. Louis, Attorney-in-Fact for Rachel Ellingson (power of attorney previously filed)
Stock symbol
ZBH
Transactions as of
Feb 21, 2023
Transactions value $
-$45,028
Form type
4
Date filed
2/23/2023, 04:52 PM
Previous filing
Jan 18, 2023
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +1.05K +27.4% $0.00 4.86K Feb 21, 2023 Direct F1, F2
transaction ZBH Common Stock Tax liability -$45K -361 -7.42% $124.73 4.5K Feb 21, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Options Exercise $0 -1.05K -100% $0.00* 0 Feb 21, 2023 Common Stock 1.05K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
F2 Includes 194 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2022.
F3 Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.
F4 Each RSU represents a contingent right to receive one share of Company common stock.